PTH and secondary hyperparathyroidism: Several studies have shown that the increase in the PTH level may be caused by a decrease in serum Ca2+ rather than a direct effect of aldosterone in patients with PA, as a low Ca2+ level may contribute to secondary hyperparathyroidism and eventually affect bone mass and strength (17, 77, 82, 88, 126, 130, 131).